Latest evidence casts further doubt on the effectiveness of headspace

Steve Kisely and Jeffrey CL Looi
Med J Aust 2023; 218 (11): . || doi: 10.5694/mja2.51944
Published online: 19 June 2023

In reply: We thank Rickwood and colleagues1 for their interest in our article.2 Given limited resources to meet the increasing need for psychiatric care, services should focus on people with clinically significant symptoms and deliver sustained improvements that are clinically, as well as statistically, significant. There should also be adequate follow‐up so that results are generalisable. We therefore used headspace's own definitions of follow‐up (90 days post‐treatment) and clinically significant improvement (only possible if presenting symptoms are of clinical severity).3,4,5 In all the cited studies,3,4,5,6 follow‐up was very low and so it is legitimate to highlight that they represent a small, unrepresentative proportion of overall headspace attendees.6

  • 1 University of Queensland, Brisbane, QLD
  • 2 Australian National University, Canberra, ACT


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.